For my next position, I want to transition from academia to the pharmaceutical industry, and keep working in research; I want to see how my effort turn out into something concrete, from which patients can really benefit one day.During my last position as postdoctoral researcher, I studied the interactome of LRRK2 and its mutated versions in cell models to better understand the role of this protein in Parkinson's Disease. By uncovering key insights into LRRK2's involvement in the disease, we can contribute to the development of more effective treatments and ultimately improve patients' lives.Previously, I focused on developing and optimizing assays to investigate glial-neuron signaling pathways in peripheral sensory neurons. By analyzing and identifying any potential perturbations, my aim was to gain a deeper understanding of the mechanisms involved in neuropathic pain and develop potential therapeutic targets for this condition.